Published in Curr Opin Hematol on January 01, 2002
Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov (2011) 4.16
Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol (2010) 3.45
The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev (2006) 2.36
Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology (2005) 1.89
Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol (2011) 1.67
Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A (2008) 1.45
The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol (2009) 1.40
A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect Immun (2005) 1.37
Antimicrobial peptides: old molecules with new ideas. J Invest Dermatol (2011) 1.34
Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. FASEB J (2009) 1.33
MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun (2003) 1.32
Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen. J Biol Chem (2009) 1.28
Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci U S A (2005) 1.26
Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun (2002) 1.24
Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. J Immunol (2012) 1.20
Paneth cell α-defensins in enteric innate immunity. Cell Mol Life Sci (2011) 1.16
Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog (2010) 1.12
Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J (2011) 1.12
The expanding world of extracellular traps: not only neutrophils but much more. Front Immunol (2013) 1.12
Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J (2005) 1.11
Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol (2002) 1.10
Intestinal mucosal responses to microbial infection. Springer Semin Immunopathol (2005) 1.10
Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res (2007) 1.06
Novel antimicrobial peptides derived from flatfish genes. Antimicrob Agents Chemother (2003) 1.03
Paneth cell alpha-defensins: peptide mediators of innate immunity in the small intestine. Springer Semin Immunopathol (2005) 1.01
Differential effects on human immunodeficiency virus type 1 replication by alpha-defensins with comparable bactericidal activities. J Virol (2004) 0.99
Paneth cell alpha-defensins from rhesus macaque small intestine. Infect Immun (2004) 0.98
Neutrophils and macrophages: the main partners of phagocyte cell systems. Front Immunol (2012) 0.97
Utilizing ESEEM spectroscopy to locate the position of specific regions of membrane-active peptides within model membranes. Biophys J (2005) 0.96
Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog (2008) 0.95
Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol (2008) 0.95
Intestinal innate immunity and the pathogenesis of Salmonella enteritis. Immunol Res (2007) 0.93
cAMP stringently regulates human cathelicidin antimicrobial peptide expression in the mucosal epithelial cells by activating cAMP-response element-binding protein, AP-1, and inducible cAMP early repressor. J Biol Chem (2009) 0.93
Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk. Interdiscip Perspect Infect Dis (2008) 0.92
Oral antimicrobial peptides: Types and role in the oral cavity. Saudi Pharm J (2015) 0.92
Modulation of epithelial immunity by mucosal fluid. Sci Rep (2011) 0.91
Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B. Biophys J (2007) 0.91
A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media. Mol Immunol (2006) 0.89
Medical-grade honey enriched with antimicrobial peptides has enhanced activity against antibiotic-resistant pathogens. Eur J Clin Microbiol Infect Dis (2010) 0.89
Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin. J Inflamm (Lond) (2006) 0.88
The adult boar testicular and epididymal transcriptomes. BMC Genomics (2009) 0.88
Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. Antimicrob Agents Chemother (2013) 0.87
The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis. J Neuroinflammation (2011) 0.86
Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11. Antimicrob Agents Chemother (2006) 0.86
Diversity in penaeidin antimicrobial peptide form and function. Dev Comp Immunol (2007) 0.86
Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. Biochemistry (2013) 0.85
Peptides and Peptidomimetics for Antimicrobial Drug Design. Pharmaceuticals (Basel) (2015) 0.85
Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides. ACS Med Chem Lett (2015) 0.84
Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases. J Biol Chem (2014) 0.84
Novel Strategies in the Prevention and Treatment of Urinary Tract Infections. Pathogens (2016) 0.83
Neutrophil-derived alpha defensins control inflammation by inhibiting macrophage mRNA translation. Proc Natl Acad Sci U S A (2016) 0.83
Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure. J Proteome Res (2013) 0.83
Bacterial Evasion of Host Antimicrobial Peptide Defenses. Microbiol Spectr (2016) 0.82
Antimicrobial Peptides in Innate Immunity against Mycobacteria. Immune Netw (2011) 0.82
Antimicrobial peptides in reptiles. Pharmaceuticals (Basel) (2014) 0.82
The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis. PLoS Pathog (2013) 0.82
Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation. Front Immunol (2015) 0.81
Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible? Clin Biochem Rev (2013) 0.81
Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cells. J Steroid Biochem Mol Biol (2014) 0.81
Molecular cloning and characterization of three beta-defensins from canine testes. Infect Immun (2005) 0.80
The heme sensing response regulator HssR in Staphylococcus aureus but not the homologous RR23 in Listeria monocytogenes modulates susceptibility to the antimicrobial peptide plectasin. BMC Microbiol (2010) 0.80
Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids. Mol Nutr Food Res (2013) 0.80
Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity. Appl Environ Microbiol (2011) 0.79
Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease. Antibiotics (Basel) (2014) 0.78
Acceleration of bone repair in NOD/SCID mice by human monoosteophils, novel LL-37-activated monocytes. PLoS One (2013) 0.78
Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells. Front Public Health (2013) 0.77
Cathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy. Transl Vis Sci Technol (2014) 0.77
Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design. PLoS One (2014) 0.77
Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities. Front Immunol (2016) 0.77
Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection. Virol J (2013) 0.76
Antibacterial activity identification of pCM19 and pCM12 derived from hGlyrichin. Springerplus (2016) 0.75
Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs. Antibiotics (Basel) (2014) 0.75
Differential activity of innate defense antimicrobial peptides against Nocardia species. BMC Microbiol (2010) 0.75
Structural and Functional Consequences Induced by Post-Translational Modifications in α-Defensins. Int J Pept (2011) 0.75
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood (2002) 7.58
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet (2003) 5.82
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med (2007) 5.18
Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05
Regulation of iron metabolism by hepcidin. Annu Rev Nutr (2006) 3.96
Hepcidin is decreased in TFR2 hemochromatosis. Blood (2004) 3.46
Defensins of vertebrate animals. Curr Opin Immunol (2002) 3.41
Suppression of hepcidin during anemia requires erythropoietic activity. Blood (2006) 3.32
Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol (2002) 3.13
The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell (2007) 2.99
Hepcidin in iron overload disorders. Blood (2005) 2.88
Systemic iron homeostasis. Physiol Rev (2013) 2.69
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood (2005) 2.66
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood (2009) 2.65
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.61
Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A (2005) 2.60
Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica (2007) 2.52
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood (2007) 2.51
Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis. Br J Haematol (2008) 2.25
Retracted The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab (2008) 2.25
Proinflammatory state, hepcidin, and anemia in older persons. Blood (2010) 2.19
Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol (2002) 2.17
The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A (2005) 2.10
Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood (2005) 2.08
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood (2010) 2.03
Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol (2007) 2.02
Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics (2005) 1.97
Detection, evaluation, and management of iron-restricted erythropoiesis. Blood (2010) 1.93
The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem (2002) 1.89
The role of hepcidin in iron metabolism. Acta Haematol (2009) 1.88
Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol (2003) 1.88
Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology (2011) 1.82
Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol (2003) 1.82
Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood (2007) 1.78
Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis (2007) 1.76
Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest (2007) 1.72
Antimicrobial components of vaginal fluid. Am J Obstet Gynecol (2002) 1.67
Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene. Blood (2004) 1.64
Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis (2004) 1.63
The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood (2005) 1.60
Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer (2007) 1.58
Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol (2002) 1.58
Increased genomic copy number of DEFA1/DEFA3 is associated with susceptibility to severe sepsis in Chinese Han population. Anesthesiology (2010) 1.58
Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res (2008) 1.57
Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol (2006) 1.55
By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol (2003) 1.54
The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood (2009) 1.51
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood (2012) 1.51
Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab (2010) 1.50
Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest (2011) 1.49
Hepcidin and iron-loading anemias. Haematologica (2006) 1.49
Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol (2009) 1.48
Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood (2004) 1.44
Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab (2012) 1.42
Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol (2005) 1.41
Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun (2005) 1.41
Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis (2007) 1.40
Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun (2006) 1.40
Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood (2005) 1.38
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood (2010) 1.37
Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol (2002) 1.35
A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood (2013) 1.34
Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans. Biol Reprod (2003) 1.32
Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood (2012) 1.32
TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol (2005) 1.31
Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest (2006) 1.30
Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica (2006) 1.23
Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica (2011) 1.21
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis (2007) 1.20
Inhibition of hepcidin transcription by growth factors. Hepatology (2012) 1.17
Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier. Am J Respir Crit Care Med (2010) 1.10
Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology (2013) 1.08
Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol (2010) 1.07
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica (2010) 1.07
Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood (2009) 1.04
Activation of a Src-dependent Raf-MEK1/2-ERK signaling pathway is required for IL-1alpha-induced upregulation of beta-defensin 2 in human middle ear epithelial cells. Biochim Biophys Acta (2002) 1.02
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica (2007) 1.01
Differential Processing of {alpha}- and {beta}-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7). J Biol Chem (2009) 1.01
Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab (2012) 1.00
Animal models of anemia of inflammation. Semin Hematol (2009) 0.99
Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun (2013) 0.99
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. J Hepatol (2008) 0.97
Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M. J Leukoc Biol (2005) 0.95
Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology (2005) 0.95
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. Blood (2011) 0.94
Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response. Am J Hematol (2009) 0.92
Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J Hepatol (2009) 0.92
A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther (2002) 0.91
High-throughput screening of small molecules identifies hepcidin antagonists. Mol Pharmacol (2013) 0.91
Angiogenin: an antimicrobial ribonuclease. Nat Immunol (2003) 0.90
Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation. Transplantation (2004) 0.90
Copy number polymorphisms are not a common feature of innate immune genes. Genomics (2006) 0.89
The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia. Haematologica (2011) 0.89
Cellular catabolism of the iron-regulatory peptide hormone hepcidin. PLoS One (2013) 0.87
Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome. Br J Haematol (2011) 0.87